Trial intelligence / Profile preview

Focalin XR vs Placebo in Children with ADHD

NCT00564954Phase 4Completed

Sponsor
Novartis
Start
Oct 2007
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmethylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Novartis. Started Oct 2007; status: completed.

02

Drugs

dexmethylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00564954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00564954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call